Emulate

By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro models that empower researchers to explore the biological mechanisms of health and disease. Since our inception, we have been focused on delivering exceptional science across multiple organs and applications. Jim Corbett has served as a leader of successful international businesses across diverse sectors, including biotechnology, medical imaging, analytical instruments and in vitro diagnostics. Ingber has authored more than 500 publications and over 160 issued or pending patents, founded 5 companies, and has been a guest speaker at more than 550 events internationally. Daniel Levner is the Chief Technology Officer at Emulate. A serial deep-tech entrepreneur, Levner co-founded Emulate and brings to it extensive experience in biological and engineering technology development and commercialization. Prior to joining Emulate, Kantor was Chief Financial Officer for Gemini Bioproducts, a private equity sponsored provider of cell culture media, sera and reagents, located in Northern California. Lorna additionally provides scientific supervision for the Emulate R&D and Services teams while also serving as the company’s European leader.